ACTIVE

LIFESTREAM PHARMA

Financial year 2025 · Closed on 31/12/2025

Net result-99,1 k €-388,6 %over 1 year

Gross margin166,7 k €-31,7 %over 1 year

Equity1,1 M €-8,4 %over 1 year

Identity

Source · BCE/KBO

LIFESTREAM PHARMA is a Public limited company incorporated in 2000. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Seneffe.

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0471.383.178
Incorporation: 07/03/2000
Legal form: Public limited company
Registered office: Rue Jules Bordet 69
7180 Seneffe · WallonieSee on map
Contributed capital: 1 835 995,30 €
Latest accounts: 31/12/2025

Activities (NACE)

46460Wholesale of pharmaceutical goods· main 46460Wholesale of pharmaceutical goods

Joint committees (1)

Signals

Solid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 19 filings

Trend over 19 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	166,7 k €	-31.7%	244 k €	-35.5%	378,1 k €	+1728%	20,7 k €	-95.2%	435 k €
EBITDA	86,9 k €	-64.2%	243 k €	-35.6%	377,1 k €	+1804%	19,8 k €	-95.4%	435 k €
Operating result	-92 k €	-284%	49,9 k €	-75.0%	199,8 k €	+281%	-110,3 k €	-133%	333,1 k €
Net result	-99,1 k €	-389%	34,3 k €	-82.0%	191 k €	+261%	-118,7 k €	-137%	325,1 k €
Balance sheet
Equity	1,1 M €	-8.4%	1,2 M €	-6.4%	1,3 M €	-0.7%	1,3 M €	-8.6%	1,4 M €
Total assets	1,4 M €	-0.8%	1,4 M €	-20.4%	1,7 M €	+12.4%	1,6 M €	-15.5%	1,8 M €
Cash	581,9 k €	+65.6%	351,3 k €	+36.8%	256,8 k €	-38.5%	417,4 k €	-41.1%	708,9 k €
Debts	294,9 k €	+40.4%	210,1 k €	-56.6%	484,5 k €	+71.5%	282,5 k €	-37.1%	449,1 k €
Other
Workforce	–		–		–		–		–

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

5 active · 12 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
John Hathaway	Director03/11/2025 → 30/04/2031
John Hauck	Director03/11/2025 → 30/04/2031
John-fils Hathaway	Director03/11/2025 → 30/04/2031
Michel Knops	Director30/06/2022 → 17/05/2028
Susan Fowler	Director30/06/2022 → 17/05/2028

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
LE CONDITIONNEMENT BELGE0402.133.096Represented by Michel Knops	Managing director02/05/2017 → 2022 accountsDirector22/04/2015 → 2015 accounts
uCure SarlRepresented by Susan Fowler	Director02/05/2017 → 2022 accounts
Profyt Management & InvestmentsRepresented by René van der Kwaak	Director22/04/2015 → 2015 accounts

Other companies at this address

Rue Jules Bordet 69 7180 Seneffe

Company	CBE no.
CIFEL● Active	0763.457.207
EUROPEAN HAIR CARE● Active	0437.507.711
Facopar● Active	0405.664.094
IMMO-K● Active	0475.408.381
LE CONDITIONNEMENT BELGE● Active	0402.133.096

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Micro model	Micro model	Micro model	Micro model	Micro model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	22/06/2026	18/06/2025	14/06/2024	31/05/2023	21/06/2022	06/05/2021
General meeting	05/05/2026	06/05/2025	07/05/2024	02/05/2023	03/05/2022	04/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 19 filings

Model	Closing	General meeting	Filed	Language	Document
Micro model	31/12/2025	05/05/2026	22/06/2026	French	PDF
Micro model	31/12/2024	06/05/2025	18/06/2025	French	PDF
Micro model	31/12/2023	07/05/2024	14/06/2024	French	PDF
Micro model	31/12/2022	02/05/2023	31/05/2023	French	PDF
Micro model	31/12/2021	03/05/2022	21/06/2022	French	PDF
Abridged model	31/12/2020	04/05/2021	06/05/2021	French	PDF
Abridged model	31/12/2019	05/05/2020	29/07/2020	French	PDF
Abridged model	31/12/2018	07/05/2019	27/06/2019	French	PDF
Abridged model	31/12/2017	08/05/2018	17/05/2018	French	PDF
Abridged model	31/12/2016	02/05/2017	10/05/2017	French	PDF
Abridged model	31/12/2015	03/05/2016	17/05/2016	French	PDF
Abridged model	31/12/2014	22/04/2015	18/05/2015	Dutch	PDF
Abridged model	31/12/2013	06/05/2014	08/05/2014	Dutch	PDF
Abridged model	31/12/2012	07/05/2013	16/05/2013	Dutch	PDF
Abridged model	31/12/2011	02/05/2012	29/05/2012	Dutch	PDF
Abridged model	31/12/2010	16/05/2011	15/06/2011	Dutch	PDF
Abridged model	31/12/2009	04/05/2010	03/06/2010	Dutch	PDF
Abridged model	31/12/2008	31/07/2009	21/08/2009	Dutch	PDF
Abridged model	31/12/2007	25/06/2008	31/07/2008	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

5 active · 12 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
John Hathaway	Director03/11/2025 → 30/04/2031
John Hauck	Director03/11/2025 → 30/04/2031
John-fils Hathaway	Director03/11/2025 → 30/04/2031
Michel Knops	Director30/06/2022 → 17/05/2028
Susan Fowler	Director30/06/2022 → 17/05/2028

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
LE CONDITIONNEMENT BELGE0402.133.096Represented by Michel Knops	Managing director02/05/2017 → 2022 accountsDirector22/04/2015 → 2015 accounts
uCure SarlRepresented by Susan Fowler	Director02/05/2017 → 2022 accounts
Profyt Management & InvestmentsRepresented by René van der Kwaak	Director22/04/2015 → 2015 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates10/12/2025
DEMISSIONS, NOMINATIONS
PDF
Mandates28/08/2023
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
PDF
Other02/08/2017
Modification du conseil d'administration
PDF
Other02/02/2017
Modification du conseil d'administration
PDF
Capital / shares13/11/2015
CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Registered office16/10/2015
ZETELVERPLAATSING — HET AANNEMEN VAN EEN
PDF
Mandates18/06/2015
Ontsiagen en benoemingen
PDF
Mandates22/01/2015
Statutenwijziging - kapitaalverhoging - ontslag bestuurder - benoeming
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings19 filings

Mandates

John-fils Hathaway

John Hathaway

John Hauck

Michel Knops

Susan Fowler

LE CONDITIONNEMENT BELGE

uCure Sarl

Profyt Management & Investments

uCure Pharma Sarl

Piet Ijzer

PinC

Canius Management

Show the 5 other mandates

20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028202920302031

LIFESTREAM PHARMA

Rue Jules Bordet 69, 7180 Seneffe

Director

Managing director

Director

DirectorManaging director

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Rue Jules Bordet 69, 7180 SeneffeCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00194471

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
LIFESTREAM PHARMACurrent	accounts 2008 → 2025	Accounts 2025 · 2026-00194471
BIO - X - HEALTHCARE	accounts 2007	Accounts 2007 · 2008-53500288

Events

2025
Annual accounts 2025-99,1 k €↓
2024
Annual accounts 202434,3 k €↓
2023
Annual accounts 2023191 k €↑
2022
Annual accounts 2022-118,7 k €↓
2021
Annual accounts 2021325,1 k €↑
2020
Annual accounts 202090 k €↑
2019
Annual accounts 20195,7 k €↓
2018
Annual accounts 201830,7 k €↑
2017
Annual accounts 2017-98,5 k €↑
2016
Annual accounts 2016-164,9 k €↓
2015
Annual accounts 2015-15,7 k €↑
2014
Annual accounts 2014-202,1 k €↓
2013
Annual accounts 2013162,4 k €↑
2012
Annual accounts 2012-36,8 k €↑
2011
Annual accounts 2011-152,5 k €↓
2010
Annual accounts 201028,6 k €↓
2009
Annual accounts 200954,8 k €↑
2008
Annual accounts 2008-469,9 k €↑
2008
Name changeLIFESTREAM PHARMA
2007
Annual accounts 2007-486,4 k €
07/03/2000
IncorporationPublic limited company

LIFESTREAM PHARMA

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events